The physics of protein folding and of non-conventional drug design: Attacking AIDS with its own weapons

Rivista del Nuovo Cimento

Volumn 29, Issue 3-4, 2006, Pages 1-119

  Broglia, R A ^a   Tiana, G ^a   Sutto, L ^a   Provasi, D ^a   Simona, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947675227     PISSN: 0393697X     EISSN: None     Source Type: Journal    
DOI: 10.1393/ncr/i2006-10011-7     Document Type: Article

References (75)

1. FEHRST A., Structure and Mechanism in Protein Science (Garland Publishing Inc., New York) 1999.
2. CREIGHTON T., Proteins. Structure and Molecular Properties (W. H. Freeman & Co, New York) 1992.
3. MIYAZAWA S. and JERNIGAN R., Estimation of effective inter-residue contact energies from protein crystal structures: quasi-chemical approximation, Macromolecules, 18 (1985) 534.
4. SHAKHNOVICH E. I., Theoretical studies of protein-folding thermodynamics and kinetics, Curr. Opin. Struct. Biol., 7 (1997) 29.
5. SHAKHNOVICH E. I., Modeling protein folding: The beauty and power of simplicity, Folding and Design 1, 3 (1996) R50.
6. GOLDSTEIN R., LUTHEY-SCHULTEN Z. and WOLYNES P., Optimal folding codes from spin-glass theory, Proc. Natl. Acad. Sci. USA, 89 (1992) 4918.
7. SALI A., SHAKHNOVICH E. I. and KARPLUS M., Kinetics of protein folding: a lattice model study for the requirements for folding to the native state, J. Mol. Biol. 235 (1994) 1614.
8. BOWIE J., LUTHEY-SHULTEN R. and EISEMBERG D., A method to identify protein sequences that fold into a known three-dimensional structure, Science, 253 (1991) 164.
9. BROGLIA R. A., TIANA G., ROMAN H. E., VIGEZZI E. and SHAKHNOVICH E. I., Stability of designed proteins against mutations, Phys. Rev. Lett., 82 (1999) 4727.
10. VERDIER P. H., Monte Carlo studies of lattice-model polymer chains. III. Relaxation of Rouse coordinates, J. Chem. Phys., 59 (1973) 6119.
11. HILHORST H. J. and DEUTCH J. M., Analysis of Monte Carlo results on the kinetics of lattice polymer chains with excluded volume, J. Chem. Phys., 63 (1975) 5153.
12. SHAKHNOVICH E. I., FARZTDIMOV G., GUTIN A. M. and KARPLUS M., Protein folding bottlenecks: A lattice Monte Carlo simulation, Phys. Rev. Lett., 67 (1991) 1665.
13. BRANDEN C. and TOOZE J., Introduction to Protein Structure (Garland Publishing, Inc., New York) 1998.
14. BRENNER S. E., CHOTHIA C. and HUBBARD T. J., Population statistics of protein structures: lessons from structural classifications, Curr. Opin. Struct. Biol., 7 (1997) 369.
15. ROST B., Protein structures sustain evolutionary drift, Folding and Design, 2 (1997) S19.
16. GOVINDARAJAN S. and GOLDSTEIN R., Evolution of Model Proteins on a Foldability Landscape, Proteins, 29 (1997) 461.
17. SHAKHNOVICH E. I. and GUTIN A., Engineering of stable and fast-folding sequences of model proteins, Proc. Natl Acad. SCi. USA, (1993) 90 7195.
18. SHAKHNOVICH E. I. and GUTIN A., A new approach to the design of stable proteins, Prot. Eng., (1993) 6 793.
19. SHAKHNOVICH E. I., Proteins with selected sequences fold into unique native conformation, Phys. Rev. Lett., 72 (1994) 3907.
20. MIRNY L., ABKEVICH V. and SHAKHNOVICH E., How evolution makes proteins fold quickly, Proc. Natl. Acad. Sci. USA, 95 (1998) 4976.
21. GOVINDARAJAN S. and GOLDSTEIN R. A., On the Thermodynamic Hypothesis of Protein Folding, Proc. Natl. Acad. Sci. USA, 95 (1998) 5545.
22. BROGLIA R. A. and TIANA G., Hierarchy of events in the folding of model protein, J. Chem. Phys., 114 (2001) 7267.
23. SHAKHNOVICH E. I., ABKEVICH V. and PTITSYN O., Conserved residues and the mechanism of protein folding, Nature, 379 (1996) 96.
24. ABKEVICH V. I., GUTIN A. M. and SHAKHNOVICH E. I., Specific nucleus as the transition-state for protein-folding - Evidence from the lattice model, Biochemistry, 33 (1994) 10026.
25. BROGLIA R. A. and TIANA G., Reading the three-dimensional structure of a protein from its amino acid sequence, Prot. Struct. Funct. Desig., 45 (2001) 421.
26. ABKEVICH V. I., GUTIN A. M. and SHAKHNOVICH E. I., Impact of local and nonlocal interactions on thermodynamics and kinetics of protein-folding, J. Mol. Biol., 252 (1998) 460.
27. TIANA G. and BROGLIA R. A., Statistical analysis of native contact formation in the folding of design proteins, J. Chem. Phys., 114 (2001) 2503.
28. BROGLIA R. A., TIANA G., PASQUALI S., ROMAN H. E. and VIGEZZI E., Folding and Aggregation of Designed Protein Chains, Proc. Natl. Acad. Sci. USA, 95 (1998)12930.
29. TIANA G. and BROGLIA R. A., Folding and design of dimeric proteins, Proteins, 49 (2002) 82.
30. TOMASSELLI A. G. and HEINRIKSON R. L., Targetting the HIV-Protease in AIDS therapy: A current clinical perspective, Biochem. Biophys. Acta, 1477 (2000) 189.
31. BROGLIA R. A., TIANA G., SUTTO L., PROVASI D. and SIMONA F., Design of HIV-1-PR inhibitors which do not create resistance: blocking the folding of single monomers, Prot. Sci., 14 (2005) 2668.
32. BROGLIA R. A., PROVASI D., VASILE F., OTTOLINA G., LONGHI R. and TIANA G., A folding inhibitor of the HIV-1 Protease, Proteins, 62 (2006) 928.
33. XIE D., GULNIK S., GUSTCHINA E., YU B., SHAO W., QORONFLEH W., NATHAN A. and ERICKSON J. W., Drug resistance mutations can affect dimer stability of HIV-1 protease or neutral pH, Prot. Sci., 8 (1999) 1702.
34. ISHIMA R., GHIRLANDO R., TODZSER J., GRONENBORN A. M., TORCHIA D. A. and LOUIS J. M., Folded monomer of HIV-1 protease, J. Biol. Chem., 276 (2001) 49110.
35. LEVY Y. and CAFLISCH A., The flexibility of monomeric and dimeric HIV-1 PR, J. Phys. Chem. B, 107 (2003) 3068.
36. LEVY Y., CAFLISCH A., ONUCHIC J. N. and WOLYNES P. G., The folding and dimerization of HIV-1 Protease: evidence for a stable monomer from simulations, J. Mol. Biol., 340 (2004) 67.
37. TIANA G., BROGLIA R. A., ROMAN H. E., VIGEZZI E. and SHAKHNOVICH E. I., Folding and misfolding of designed protein-like chains with mutations, J. Chem. Phys., 108 (1998) 757.
38. WALLQVIST A., SMYTHERS GW. and COVELL D. G., A cooperative folding unit in HIV-1 protease. Implications fo protein stability and occurrence of drug-induced mutations, Prot. Eng., 11 (1998) 999.
39. BAHAR I., ATILGAN A. R., DEMIREL M. C. and ERMAN B., Vibrational dynamics of folded proteins: significance of slow and fast motions in relation to function and stability, Phys. Rev. Lett., 80 (1998) 2733.
40. CECCONI F., MICHELETTI C., CARLONI P. and MARITAN A., Molecular dynamics studied on HIV-1 Protease drug resistance and folding pathways, Proteins, 43 (2003) 365.
41. KURT N., SCOTT W. R., SCHIFFER C. A. and HALILOGLU T., Cooperative fluctuations of unliganded and substrate-bound HIV-1 Protease: a structure base analysis on a variety of conformations from crystallography and molecular dynamics simulations, Proteins, 51 (2003) 409.
42. DYSON H. J. and WRITE P. E., Peptide conformation and protein folding, Curr. Opin. Struct. Biol., 3 (1993) 60.
43. WU L. C., GRANDORRI R. and CAREY J., Autonomous Subdomains in Protein Folding, Prot. Sci., 3 (1994) 371.
44. BAI Y., MULUE J. S., MAYNE L. and ENGLANDER S. W., Primary structure effects on peptide group hydrogen exchange, Proteins, 17 (1993) 75.
45. JAENICKE R., Protein folding: local structures, domains, subunits and assemblies, Biochem., 30 (1991) 3147.
46. WALLQVIST A., SMITHERS G. W. and COVELL D. G., Identification of cooperative folding units in a set of native proteins, Prot. Sci., 6 (1997) 1627.
47. HOLM L. and SANDER C., Mapping the protein universe, Science, 273 (1996) 595.
48. BERENDSEN H. J.C., VAN DER SPOEL D. and VAN DRUNEN R., GROMACS: A message-passing parallel molecular dynamics implementation, Comp. Phys. Comm., 91 (1995) 43.
49. TIANA G., SIMONA F., DE MORI G. M. S., BROGLIA R. A. and COLOMBO G., Understanding the determinants of small globular proteins from their energetics, Prot. Sci., 13 (2004) 113.
50. RICHMAN D. D., Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents, Anitmicrob. Agents Chemother., 37 (1993) 1207.
51. DE CLERCQ E., HIV resistance to reverse transcriptase inhibitors, Biochem. Pharmacol., 47 (1994) 155.
52. VASUDEVACHARI M.B., ZHANG Y.M., IMAMICHI H., IMAMICHI T. FALLON J. and SALZMAN N. P., Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection, Antimicrob. Agents Chemother., 40 (1996) 2535.
53. BROGLIA R. A., TIANA G. and BERERA R., Resistance proof, folding-inhibitor drugs, J. Chem. Phys., 118 (2003) 4754.
54. BROGLIA R. A. and TIANA G., Predicting the Three Dimensional Structure of a Lattice Designed Model Protein from its Primary Structure, J. Biol. Phys., 27 (2001) 161.
55. BONVIN A. M. and VAN GUNSTEREN W. F., Beta-hairpin stability and folding: molecular dynamics studies of the first beta-hairpin of tendamistat, J. Mol. Biol., 296 (2000) 255.
56. LEVY Y., WOLYNES P. G. and ONUCHIC J. N., Protein topology determines binding mechanism, Proc. Natl. Acad. Sci. USA, 101 (2004) 511.
57. BORG J., Optimized Monte Carlo analysis for generalized ensembles, Eur. Phys. J. B., 20 (2001) 481.
58. YAMAZAKI T., HINCK A. P., WANG Y. X., NICHOLSON L. K., TORCHIA D. A., WINGFIELD P., STAHL S. J., KAUFMAN J. D., CHANG C. H., DOMAILLE P. J., LAM P. Y., Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy, Prot. Sci., 5 (1996) 495.
59. ROBERTS N. A., et al., Rational design of peptide-based HIV proteinase inhibitors, Science, 248 (1990) 358.
60. KROHN A. et al., Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere, J. Med. Chem., 34 (1991) 3340.
61. NORTHROP J. H., Crystalline pepsin. I. Isolation and tests of purity, J. Gen. Physiol., 13 (1930) 739.
62. HOLM L. and SANDER C., Dictionary of recurrent domains in protein structures, Proteins, 33 (1998) 88.
63. RUSCONI S., LO CICERO M., FERRAMOSCA S., SIRIANNI F., GALLI M., MORONI M., LAFACE A. E., CESANA E. and CLIVIO A., private communication.
64. MIRNY L. and SHAKHNOVICH E. I., Universally conserved positions in protein folds: reading evolutionary signals about stability, folding kinetics and function, J. Mol Biol., 291 (1999) 177.
65. BALDWIN R. L. and ROSE G. D., Is protein folding hierarchic?, TIBS, 24 (1990) 26.
66. GOODSELL D. S. and OLSON A. J., Soluble proteins: size, shape and function, Trends Biochem. Sci., 18 (1983) 65.
67. RICHARDSON J. S., The anatomy and taxonomy of protein structure, Adv. Prot. Chem., 34 (1981)167.
68. JANIN J. and WODAK S. J., Structural domains in proteins and their role in the dynamics of protein function, Prog. Biophys. Mol. Biol., 42 (1983) 21.
69. SUTTO L., TIANA G. and BROGLIA R. A., Sequence of events in folding mechanism: beyond the Go model, Prot. Sci., 15 (2006) 1638.
70. SHAFER R. W., HU P., PATICK A. K., CRAIG C. and BRENDEL V., Identification of biased amino acid substitution patterns in human immunodeficiency virus type 1 isolates from patients treated with protease inhibitors, J. Virol., 73 (1999) 6197.
71. GUEROIS R. and SERRANO L., The SH3-fold family: experimental evidence and prediction of variations in the folding pathways, J. Mol. Biol., 304 (2000) 967.
72. KABSCH W. and SANDER C., Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features, Biopolymers, 22 (1983) 2577.
73. TIANA G., SUTTO L. and BROGLIA R. A., Use of the Metropolis algorithm to simulate the dynamics of protein chains, arXiv:q-bio.OT/0606038.
74. BROGLIA R. A., TIANA G., SUTTO L., PROVASI D., PERELLI V., Low-throughput model design of protein folding inhibitors, to be published in Proteins.
75. TIANA G., BROGLIA R. A. and SHAKHNOVICH E. I., Hiking in the energy landscape in sequence space: a bumpy road to good folders, Proteins, 39 (2000) 244.